Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Genetic Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Cancer Biomark. 2016;16(1):31-45. doi: 10.3233/CBM-150538.
Non-small cell lung cancers (NSCLCs) is a prevalent and heterogeneous subtype of lung cancer accounting for 85 percent of patients. MicroRNAs (miRNAs), a class of small endogenous non-coding RNAs, incorporate into regulation of gene expression post-transcriptionally. Therefore, deregulation of miRNAs' expression has provided further layers of complexity to the molecular etiology and pathogenesis of different diseases and malignancies. Although, until now considerable number of studies has been carried out to illuminate this complexity in NSCLC, they have remained less effective in their goal due to lack of a holistic and integrative systems biology approach which considers all natural elaborations of miRNAs' function. It is able to reliably nominate most affected signaling pathways and therapeutic target genes by deregulated miRNAs during a particular pathological condition. Herein, we utilized a holistic systems biology approach, based on appropriate re-analyses of microarray datasets followed by reliable data filtering, to analyze integrative and combinatorial deregulated miRNA-mRNA interaction network in NSCLC, aiming to ascertain miRNA-dysregulated signaling pathway and potential therapeutic miRNAs and mRNAs which represent a lion' share during various aspects of NSCLC's pathogenesis. Our systems biology approach introduced and nominated 1) important deregulated miRNAs in NSCLCs compared with normal tissue 2) significant and confident deregulated mRNAs which were anti-correlatively targeted by deregulated miRNA in NSCLCs and 3) dysregulated signaling pathways in association with deregulated miRNA-mRNAs interactions in NSCLCs. These results introduce possible mechanism of function of deregulated miRNAs and mRNAs in NSCLC that could be used as potential therapeutic targets.
非小细胞肺癌(NSCLC)是一种常见且具有异质性的肺癌亚型,占患者的 85%。微小 RNA(miRNA)是一类小型内源性非编码 RNA,通过转录后调控基因表达。因此,miRNA 表达的失调为不同疾病和恶性肿瘤的分子病因和发病机制提供了进一步的复杂性。尽管到目前为止,已经进行了相当数量的研究来阐明 NSCLC 中的这种复杂性,但由于缺乏整体和综合的系统生物学方法,考虑到 miRNA 功能的所有自然表达,这些研究在其目标上仍然效果不佳。这种方法能够可靠地提名在特定病理条件下失调 miRNA 调控的大多数受影响的信号通路和治疗靶基因。在此,我们利用了一种整体系统生物学方法,基于对微阵列数据集进行适当的重新分析,然后进行可靠的数据过滤,来分析 NSCLC 中整合和组合失调的 miRNA-mRNA 相互作用网络,旨在确定 miRNA 失调的信号通路和潜在的治疗性 miRNA 和 mRNA,这些在 NSCLC 发病机制的各个方面都代表着很大的份额。我们的系统生物学方法提出并提名了 1)与正常组织相比,在 NSCLCs 中失调的重要 miRNA;2)在 NSCLCs 中与失调 miRNA 反相关靶向的显著且可靠的失调 mRNA;3)与失调 miRNA-mRNA 相互作用相关的失调信号通路。这些结果介绍了失调 miRNA 和 mRNA 在 NSCLC 中的可能功能机制,可作为潜在的治疗靶点。